These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Ocular manifestations in patients with Stevens-Johnson syndrome in Malawi-review of the literature illustrated by clinical cases. Schulze Schwering M; Kayange P; Rothe C Graefes Arch Clin Exp Ophthalmol; 2019 Nov; 257(11):2343-2348. PubMed ID: 31352606 [TBL] [Abstract][Full Text] [Related]
6. Plasmapheresis, Intravenous Immunoglobulins, and Autologous Serum Eyedrops in the Acute Eye Complications of Toxic Epidermal Necrolysis. Pinna A; Nuvoli E; Blasetti F; Posadinu MA; Boscia F Eur J Ophthalmol; 2017 Nov; 27(6):658-663. PubMed ID: 28362052 [TBL] [Abstract][Full Text] [Related]
7. Contact lens management of a case of Stevens-Johnson syndrome: a case report. Fine P; Savrinski B; Millodot M Optometry; 2003 Oct; 74(10):659-64. PubMed ID: 14606579 [TBL] [Abstract][Full Text] [Related]
9. Allopurinol-induced toxic epidermal necrolysis. Dan M; Jedwab M; Peled M; Shibolet S Int J Dermatol; 1984 Mar; 23(2):142-4. PubMed ID: 6698688 [TBL] [Abstract][Full Text] [Related]
10. Successful treatment of Stevens-Johnson syndrome with steroid pulse therapy at disease onset. Araki Y; Sotozono C; Inatomi T; Ueta M; Yokoi N; Ueda E; Kishimoto S; Kinoshita S Am J Ophthalmol; 2009 Jun; 147(6):1004-11, 1011.e1. PubMed ID: 19285657 [TBL] [Abstract][Full Text] [Related]
11. A cross-sectional comparative study on chronic ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year case series. Chow LLW; Ng ALK; Chow SSW; Choy BNK; Shih KC; Wong IYH; Chan JCY; Lai JSM Int Ophthalmol; 2018 Jun; 38(3):1155-1160. PubMed ID: 28547534 [TBL] [Abstract][Full Text] [Related]
12. Amniotic membrane with living related corneal limbal/conjunctival allograft for ocular surface reconstruction in Stevens-Johnson syndrome. Gomes JA; Santos MS; Ventura AS; Donato WB; Cunha MC; Höfling-Lima AL Arch Ophthalmol; 2003 Oct; 121(10):1369-74. PubMed ID: 14557171 [TBL] [Abstract][Full Text] [Related]
13. Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications. Sotozono C; Ueta M; Koizumi N; Inatomi T; Shirakata Y; Ikezawa Z; Hashimoto K; Kinoshita S Ophthalmology; 2009 Apr; 116(4):685-90. PubMed ID: 19243825 [TBL] [Abstract][Full Text] [Related]
14. Ocular Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children. Catt CJ; Hamilton GM; Fish J; Mireskandari K; Ali A Am J Ophthalmol; 2016 Jun; 166():68-75. PubMed ID: 27018234 [TBL] [Abstract][Full Text] [Related]
17. Stevens-Johnson syndrome, drug-induced hypersensitivity syndrome and toxic epidermal necrolysis caused by allopurinol in patients with a common HLA allele: what causes the diversity? Dainichi T; Uchi H; Moroi Y; Furue M Dermatology; 2007; 215(1):86-8. PubMed ID: 17587850 [No Abstract] [Full Text] [Related]
18. Asymptomatic hyperuricaemia and allopurinol induced toxic epidermal necrolysis. Auböck J; Fritsch P Br Med J (Clin Res Ed); 1985 Jun; 290(6486):1969-70. PubMed ID: 3924329 [No Abstract] [Full Text] [Related]
19. Tear exchangeable limbal rigid contact lens for ocular sequelae resulting from Stevens-Johnson syndrome or toxic epidermal necrolysis. Sotozono C; Yamauchi N; Maeda S; Kinoshita S Am J Ophthalmol; 2014 Nov; 158(5):983-93. PubMed ID: 25036881 [TBL] [Abstract][Full Text] [Related]
20. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population. Tassaneeyakul W; Jantararoungtong T; Chen P; Lin PY; Tiamkao S; Khunarkornsiri U; Chucherd P; Konyoung P; Vannaprasaht S; Choonhakarn C; Pisuttimarn P; Sangviroon A; Tassaneeyakul W Pharmacogenet Genomics; 2009 Sep; 19(9):704-9. PubMed ID: 19696695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]